Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


10.04.2017

3 Am J Gastroenterol
1 Ann Intern Med
1 BMC Gastroenterol
4 Clin Infect Dis
1 Dig Dis Sci
8 Hepatology
1 Int J Cancer
1 J Hepatol
1 J Immunol
1 J Infect Dis
1 J Interferon Cytokine Res
2 J Med Virol
2 J Viral Hepat
5 PLoS One
2 Transplant Proc
1 Transplantation
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. GARCIA-SAENZ-DE-SICILIA M, Duvoor C, Altamirano J, Chavez-Araujo R, et al
    Corrigendum: A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Am J Gastroenterol. 2017;112:666.
    PubMed     Text format    

  2. OOKA K, Connolly JJ, Lim JK
    Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Text format    

  3. CHON YE, Park JY, Myoung SM, Jung KS, et al
    Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    Ann Intern Med

  4. BUCKLEY GJ, Strom BL
    A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis C.
    Ann Intern Med. 2017 Apr 4. doi: 10.7326/M17-0766.
    PubMed     Text format    


    BMC Gastroenterol

  5. BANG CS, Song IH
    Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis.
    BMC Gastroenterol. 2017;17:46.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  6. NOSKA AJ, Belperio PS, Loomis TP, O'Toole TP, et al
    Prevalence of HIV, HCV and HBV among Homeless and Non-homeless United States Veterans.
    Clin Infect Dis. 2017 Apr 1. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. HEZODE C, Fourati S, Chevaliez S, Scoazec G, et al
    Sofosbuvir-Daclatasvir-Simeprevir plus Ribavirin in Direct-Acting Antiviral-Experienced Hepatitis C Patients.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    PubMed     Text format     Abstract available

  8. BUTT AA, Ren Y, Lo Re V 3rd, Taddei T, et al
    Comparing Child-Pugh, MELD and FIB-4 to Predict Clinical Outcomes in HCV-Infected Persons: Results from ERCHIVES.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. WYLES D, Brau N, Kottilil S, Daar ES, et al
    Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study.
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  10. DEVER JB, Ducom JH, Ma A, Nguyen J, et al
    Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.
    Dig Dis Sci. 2017 Apr 4. doi: 10.1007/s10620-017-4548.
    PubMed     Text format     Abstract available


    Hepatology

  11. MERLI M, Frigeni M, Gotti M, Grossi P, et al
    Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas.
    Hepatology. 2017 Apr 5. doi: 10.1002/hep.29198.
    PubMed     Text format    

  12. LIM YS, Lee YS, Gwak GY, Byun KS, et al
    Monotherapy with Tenofovir Disoproxil Fumarate for Multiple Drug-Resistant Chronic Hepatitis B: 3-Year Trial.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29187.
    PubMed     Text format     Abstract available

  13. FUNG J, Wong T, Chok K, Chan A, et al
    Long Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B after Liver Transplantation: Results up to 8 years.
    Hepatology. 2017 Mar 31. doi: 10.1002/hep.29191.
    PubMed     Text format     Abstract available

  14. CHANG ML, Liaw YF
    Overt acute hepatitis B is more severe in female patients.
    Hepatology. 2017 Apr 2. doi: 10.1002/hep.29196.
    PubMed     Text format    

  15. PERRILLO RP
    HBV Reactivation During DAA Treatment of Chronic Hepatitis C: A Hidden Danger of an Otherwise Major Success Story.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29185.
    PubMed     Text format    

  16. SORIA A, Fabbiani M, Lapadula G, Gori A, et al
    Unexpected viral relapses in HCV-infected patients diagnosed with hepatocellular carcinoma during treatment with DAAs.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29181.
    PubMed     Text format    

  17. FORREST E
    Clinical Criteria are Critical to Diagnosing Alcoholic Hepatitis.
    Hepatology. 2017 Apr 1. doi: 10.1002/hep.29188.
    PubMed     Text format    

  18. LAI TS, Lee MH, Yang HI, You SL, et al
    Hepatitis C Viral Load, Genotype, and Increased Risk of Developing End-stage Renal Disease: REVEAL-HCV Study.
    Hepatology. 2017 Apr 2. doi: 10.1002/hep.29192.
    PubMed     Text format     Abstract available


    Int J Cancer

  19. WEI XL, Luo HY, Li CF, Jin Y, et al
    Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30719.
    PubMed     Text format     Abstract available


    J Hepatol

  20. WESTHAUS S, Deest M, Nguyen AT, Stanke F, et al
    Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load.
    J Hepatol. 2017 Mar 28. pii: S0168-8278(17)30184.
    PubMed     Text format     Abstract available


    J Immunol

  21. JIE Z, Liang Y, Yi P, Tang H, et al
    Retinoic Acid Regulates Immune Responses by Promoting IL-22 and Modulating S100 Proteins in Viral Hepatitis.
    J Immunol. 2017 Mar 31. pii: 1601891. doi: 10.4049/jimmunol.1601891.
    PubMed     Text format     Abstract available


    J Infect Dis

  22. VAN DER REE MH, Jansen L, Kruize Z, van Nuenen AC, et al
    Plasma microRNA levels are associated with HBeAg status and treatment response in chronic hepatitis B patients.
    J Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Interferon Cytokine Res

  23. SHENEEF A, Esmat MM, Mohammad AN, Mahmoud AA, et al
    Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk.
    J Interferon Cytokine Res. 2017;37:175-180.
    PubMed     Text format     Abstract available


    J Med Virol

  24. MENDIZABAL M, Haddad L, Gallardo PE, Ferrada A, et al
    Ombitasvir/paritaprevir/ritonavir/dasabuvir +/- ribavirin is safe and effective in HCV infected patients in a real-life cohort from Latin America.
    J Med Virol. 2017 Mar 29. doi: 10.1002/jmv.24816.
    PubMed     Text format     Abstract available

  25. KHALIFA RH, Labib DA, Kamel MA, Shahin RM, et al
    Role of ApoB-516C/T promoter gene polymorphism in the risk of Hepatitis C virus infection in Egyptian patients and in gender susceptibility.
    J Med Virol. 2017 Mar 29. doi: 10.1002/jmv.24815.
    PubMed     Text format     Abstract available


    J Viral Hepat

  26. HUANG CE, Yang YH, Chen YY, Chang JJ, et al
    The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.
    J Viral Hepat. 2017 Apr 4. doi: 10.1111/jvh.12713.
    PubMed     Text format     Abstract available

  27. VUKOTIC R, Conti F, Fagiuoli S, Morelli MC, et al
    Long-term outcomes of DAAs in post-transplant advanced HCV recurrence and fibrosing cholestatic hepatitis.
    J Viral Hepat. 2017 Mar 28. doi: 10.1111/jvh.12712.
    PubMed     Text format     Abstract available


    PLoS One

  28. KACZMAREK DJ, Kokordelis P, Kramer B, Glassner A, et al
    Alterations of the NK cell pool in HIV/HCV co-infection.
    PLoS One. 2017;12:e0174465.
    PubMed     Text format     Abstract available

  29. YE Q, Yin W, Zhang L, Xiao H, et al
    The value of grip test, lysophosphatidlycholines, glycerophosphocholine, ornithine, glucuronic acid decrement in assessment of nutritional and metabolic characteristics in hepatitis B cirrhosis.
    PLoS One. 2017;12:e0175165.
    PubMed     Text format     Abstract available

  30. CHEN HC, Chung CH, Wang CH, Lin JC, et al
    Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection.
    PLoS One. 2017;12:e0175266.
    PubMed     Text format     Abstract available

  31. CHEN H, Chen L
    Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China.
    PLoS One. 2017;12:e0175189.
    PubMed     Text format     Abstract available

  32. KOMOLMIT P, Charoensuk K, Thanapirom K, Suksawatamnuay S, et al
    Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial.
    PLoS One. 2017;12:e0174608.
    PubMed     Text format     Abstract available


    Transplant Proc

  33. GARCIA BERNARDO CM, Arguelles Garcia B, Redondo Buil P, Miyar de Leon A, et al
    Collateral Development in Thrombosis of the Hepatic Artery After Transplantation.
    Transplant Proc. 2016;48:3006-3009.
    PubMed     Text format     Abstract available

  34. CHOI S, Kim KK, Lee WS, Kang JM, et al
    Living Donor Liver Transplantation in a Patient With Extensive Portomesenteric Venous Thrombosis: Case Report.
    Transplant Proc. 2016;48:3153-3155.
    PubMed     Text format     Abstract available


    Transplantation

  35. MAZZOLA A, Minh MT, Charlotte F, Hdjii A, et al
    Chronic hepatitis E viral infection after liver transplantation: a regression of fibrosis following antiviral therapy.
    Transplantation. 2017 Apr 4. doi: 10.1097/TP.0000000000001766.
    PubMed     Text format     Abstract available


    Virology

  36. KHERA L, Paul C, Kaul R
    Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1.
    Virology. 2017;506:110-120.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: